Predictors of Response to Treatment With Iron and Erythropoietin in Dialysis Anaemia

Trial Profile

Predictors of Response to Treatment With Iron and Erythropoietin in Dialysis Anaemia

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 23 Nov 2016

At a glance

  • Drugs Epoetin alfa (Primary) ; Iron sucrose (Primary)
  • Indications Anaemia
  • Focus Therapeutic Use
  • Acronyms PRIME
  • Most Recent Events

    • 18 Nov 2016 Status changed from recruiting to active, no longer recruiting.
    • 15 Mar 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top